Exclusion of HDAC1/2 complexes by oncogenic nuclear condensates

Junqi Kuang,Pengli Li,Ziwei Zhai,Yixin Fan,HuaiYuan Xu,Chengchen Zhao,Wei Li,Xiaoxi Li,Zechuan Liang,Tao Huang,Yue Qin,Huiru Gao,Zhaoyi Ma,Dong Liu,Guifa Zhong,Bo Wang,Jing Liu,Jin Wang,Micky D. Tortorella,Baojian Liao,Duanqing Pei
DOI: https://doi.org/10.1186/s12943-024-02002-1
IF: 37.3
2024-04-28
Molecular Cancer
Abstract:Nuclear condensates have been shown to regulate cell fate control, but its role in oncogenic transformation remains largely unknown. Here we show acquisition of oncogenic potential by nuclear condensate remodeling. The proto-oncogene SS18 and its oncogenic fusion SS18-SSX1 can both form condensates, but with drastically different properties and impact on 3D genome architecture. The oncogenic condensates, not wild type ones, readily exclude HDAC1 and 2 complexes, thus, allowing aberrant accumulation of H3K27ac on chromatin loci, leading to oncogenic expression of key target genes. These results provide the first case for condensate remodeling as a transforming event to generate oncogene and such condensates can be targeted for therapy.
oncology,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: the role of nuclear condensates in tumorigenesis and its mechanism. Specifically, the researchers explored how nuclear condensates formed by the proto - oncogene SS18 and its oncogenic fusion protein SS18 - SSX exclude histone deacetylase complexes (HDAC1/2 complexes), leading to abnormal accumulation of acetylated modification at histone H3K27 site (H3K27ac), thereby activating the expression of key target genes and promoting the oncogenic transformation of cells. This process reveals nuclear condensate remodeling as a new mechanism of oncogenic events and provides a potential direction for targeted therapy. ### Main findings: 1. **Formation and property differences of nuclear condensates**: - Both the proto - oncogene SS18 and the oncogenic fusion protein SS18 - SSX can form nuclear condensates, but the condensates formed by the latter have significantly different properties. - The condensates formed by SS18 - SSX are more efficient than wild - type SS18 and exhibit different molecular dynamic characteristics, which may be closer to low - valency interactions rather than liquid - liquid phase separation (LLPS). 2. **Exclusion of HDAC1/2 complexes**: - The condensates formed by SS18 - SSX can physically exclude HDAC1/2 complexes, while the condensates of wild - type SS18 allow these complexes to enter freely. - This exclusion leads to abnormal acetylated accumulation at the H3K27 site, which in turn activates the expression of key oncogenes. 3. **Changes in 3D genome structure**: - The expression of SS18 - SSX results in the remodeling of the 3D genome structure, manifested as enhanced long - distance chromatin interactions, especially in the regions with H2AK119ub modification. - These structural changes are positively correlated with the intensity of H2AK119ub modification. ### Conclusion: This study is the first to show the mechanism of nuclear condensate remodeling as an oncogenic event, that is, by excluding HDAC1/2 complexes, leading to abnormal accumulation of H3K27ac, thereby activating the expression of oncogenes. This finding not only enhances the understanding of the role of nuclear condensates in tumorigenesis but also provides a theoretical basis for the development of new anti - cancer strategies.